IP Verse

Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease - EP1793855

PATENT ANALYSIS

Patent Details

Grant Date
Jan 19, 2022
Company
ELAN PHARMACEUTICALS, INC.
Oppositions

MATHYS & SQUIRE LLP

More patents of Elan Pharmaceuticals, Inc.

EP2645106

EP1793855

EP1991267

Want to monitor this patent?

Feel free to send us a message here and we will get back to you